Outcomes and Future Directions of Per-Oral Endoscopic Pyloromyotomy: A View from France

Jérémie Jacques; Romain Legros; Jacques Monteil; Denis Sautereau; Guillaume Gourcerol

doi:10.1016/j.giec.2018.08.008

Outcomes and Future Directions of Per-Oral Endoscopic Pyloromyotomy: A View from France

Gastrointest Endosc Clin N Am. 2019 Jan;29(1):139-149. doi: 10.1016/j.giec.2018.08.008. Epub 2018 Sep 24.

Authors

Jérémie Jacques¹, Romain Legros², Jacques Monteil³, Denis Sautereau², Guillaume Gourcerol⁴

Affiliations

¹ Gastroenterology Department, Limoges University Hospital, 2 Avenue Martin Luther King, Rouen 87042, France. Electronic address: jeremiejacques@gmail.com.
² Gastroenterology Department, Limoges University Hospital, 2 Avenue Martin Luther King, Rouen 87042, France.
³ Nuclear Medicine Department, Limoges University Hospital, 2 Avenue Martin Luther King, Limoges 87042, France.
⁴ Gastroenterology Department, Rouen University Hospital, 1 rue de Germont, Rouen 76038, France.

PMID: 30396523
DOI: 10.1016/j.giec.2018.08.008

Abstract

Gastroparesis is a challenging functional gastroenterological disorder, the complex pathophysiology of which hampers development of therapeutic modalities. Per-oral pyloromyotomy (POP) is a promising endoscopic therapy with a short-term clinical success rate of greater than 80%. Interest in POP is increasing, particularly in France, a country in which there is considerable expertise in submucosal endoscopy and functional disorders. Long-term follow-up and pyloric function evaluation are needed to assess the efficacy of POP in gastroparetic patients.

Keywords: EndoFLIP; Gastric POEM; Gastroparesis; Per-oral pyloromyotomy; Refractory gastroparesis; Severe gastroparesis.

Publication types

Review

MeSH terms

Forecasting
France
Gastroparesis / surgery*
Gastroscopy
Humans
Pyloromyotomy / trends*
Pylorus / surgery*
Treatment Outcome